P&K Skin Research Center Co (XKRX:347740) Cash-to-Debt : 66.87 (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is P&K Skin Research Center Co Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. P&K Skin Research Center Co's cash to debt ratio for the quarter that ended in Dec. 2023 was 66.87.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, P&K Skin Research Center Co could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for P&K Skin Research Center Co's Cash-to-Debt or its related term are showing as below:

XKRX:347740' s Cash-to-Debt Range Over the Past 10 Years
Min: 24.28 Med: 66.87 Max: 5686.82
Current: 66.87

During the past 7 years, P&K Skin Research Center Co's highest Cash to Debt Ratio was 5686.82. The lowest was 24.28. And the median was 66.87.

XKRX:347740's Cash-to-Debt is ranked better than
90.95% of 232 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.35 vs XKRX:347740: 66.87

P&K Skin Research Center Co Cash-to-Debt Historical Data

The historical data trend for P&K Skin Research Center Co's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

P&K Skin Research Center Co Cash-to-Debt Chart

P&K Skin Research Center Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

24.28

59.91

40.46

77.55

66.87

P&K Skin Research Center Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial															77.55	57.52	58.93	65.07	66.87

Competitive Comparison of P&K Skin Research Center Co's Cash-to-Debt

For the Diagnostics & Research subindustry, P&K Skin Research Center Co's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

P&K Skin Research Center Co's Cash-to-Debt Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, P&K Skin Research Center Co's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where P&K Skin Research Center Co's Cash-to-Debt falls into.

P&K Skin Research Center Co Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

P&K Skin Research Center Co's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	44687.718	/	(354.273	+	313.962)
	=	66.87

P&K Skin Research Center Co's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	44687.718	/	(354.273	+	313.962)
	=	66.87

P&K Skin Research Center Co (XKRX:347740) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

P&K Skin Research Center Co Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of P&K Skin Research Center Co's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

P&K Skin Research Center Co (XKRX:347740) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » P&K Skin Research Center Co Ltd (XKRX:347740) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

National Assembly Road 62 -25 Yeongdeungpo-gu, Education Facility Disaster Relief Society Building, 4th Floor, Seoul, KOR, 07236

Website

http://www.pnkskin.com

P&K Skin Research Center Co Ltd is a skin research center. It provides clinical tests for new cosmetics, raw materials, and cosmeceuticals. The company provides skin irritation tests, Stimulation tests, skin wrinkle evaluation, skin texture evaluation, skin whitening evaluation, sweat proof evaluation, skin density measurement, scalp flakiness evaluation, and hair root evaluation. Also, the company provides health food tests, sensory tests, and In Vitro tests.

P&K Skin Research Center Co (XKRX:347740) Headlines

No Headlines